Role for Stereotactic Ablative Radiotherapy in Metastatic RCC?

Radiotherapy in advanced kidney cancer is generally only used in select metastatic settings, but the use of stereotactic ablative radiotherapy (SABR) offers promise in a number of indications in this malignancy. An expert in the field discussed the present state of data and what future trials may show at the 15th International Kidney Cancer Symposium, held November 4–5 in Miami, Florida.
Cancer Network